VTAKCatheter Precision, Inc. · NYSE American
Assessed Oct 9, 2026 · 8-K financing event
Is the float you're seeing correct?
2.10M
Estimated float

Started from the post-split count in the 8-K of 2026-10-05 and subtracted the insiders' issued shares.

NO REPORTED FLOAT
—
Reported float

Data-service feed, fetched today. The number TradingView and most screeners show.

Trade off 2.10M shares; data services have no usable float for this ticker.

Dilution risk9/10EXTREME
CONFIDENCE: MEDIUM

We put the float at 2.10M; data services have no usable number. An active $300K ATM, 2 floorless convertible notes and 3 reverse splits can add another 1,512% of the float. This company has cut its own floor prices before.

  • Repriceable convertible preferred (death-spiral equivalent). All Series C-1/C-2/C-3/C-4 and Series D were repriced on 2026-10-09 from $2.30 to $1.00 post-split, with floors waived.

  • Open-ended preferred investment right. The C-4 Additional Investment Right lets investors buy more preferred at about 80% of market for 12 months.

  • Insider preferred repricing. The CEO's Series J was repriced from $15.60 to $1.00 post-split, so conversion shares went from 608,300 to 9,489,488 (4.5x the float).

From today's float to the ceiling

shares
2.10M
Estimated float
tradeable today
+4.99M can sell now
7.09M
Effective supply
float plus what sells on notice
+31.73M if floors are cut and warrants exercise
38.82M
Fully diluted
ceiling

Ceiling computed from the itemised overhang.

Where the shares come from

each subtotal is a rung on the ladder above

Tradeable today
2.10M
Can sell now
Registered resale shares, issuable on notice
Already effective; the holder can sell without a further filing.
+4.99M
Warrants in the money
None of the outstanding warrants are exercisable at this price.
+0
Effective supply
7.09M
Converts only if floors are cut
Notes with no conversion price set
Sized in dollars until a price or floor is set; not counted in the ceiling.
$1.00M
Preferred stock, as converted
Common equivalent at the stated conversion ratio.
+31.56M
Above the current price
Warrants out of the money
Struck above the current tape; supply only if the stock rises.
+113.7K
Options and RSUs
Employee equity; vests and settles over time.
+50.8K
Fully diluted
38.82M

ATM program active with $300K of registered capacity remaining. Sales are paced by the agent against daily volume; the headline figure is not the near-term supply.

Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.

Engine fully-diluted count (33.83M) is below the itemised overhang; ceiling computed from the rows.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue

The facts

Price
—
Market cap
—
Shares outstanding
—
Reported float
—
Avg volume
—
Reverse splits
3 · latest 1-for-10 · Oct 5, 2026
Going concern
Yes · 0.2 quarters runway
Quarterly burn
$2.85M

Market data as of Oct 25, 2026

Key dates

  • Oct 20, 2026 · Series D and C-2 conversion shares above the registered amount become Rule 144 eligible (6 months from April 2026 issuance)
  • Nov 12, 2026 · Approximate deadline to file the C-4 resale S-1
  • Dec 15, 2026 · Final installment on the $5.0M Creatd note (default would pressure more equity raises)
  • Jan 15, 2027 · Series C-3 conversion shares become Rule 144 eligible
VTAK Float & Dilution Analysis | ShareStructure.io